Detalhe da pesquisa
1.
Rational design of a new antibiotic class for drug-resistant infections.
Nature
; 597(7878): 698-702, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34526714
2.
In vivo dose response and efficacy of the ß-lactamase inhibitor, durlobactam, in combination with sulbactam against the Acinetobacter baumannii-calcoaceticus complex.
Antimicrob Agents Chemother
; 68(1): e0080023, 2024 Jan 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38092671
3.
I n vitro pharmacokinetics/pharmacodynamics of the ß-lactamase inhibitor, durlobactam, in combination with sulbactam against Acinetobacter baumannii-calcoaceticus complex.
Antimicrob Agents Chemother
; 68(1): e0031223, 2024 Jan 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38092676
4.
Pharmacokinetic/Pharmacodynamic Determination and Preclinical Pharmacokinetics of the ß-Lactamase Inhibitor ETX1317 and Its Orally Available Prodrug ETX0282.
ACS Infect Dis
; 6(6): 1378-1388, 2020 06 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32379415
5.
High prevalence of spirochetosis in cholera patients, Bangladesh.
Emerg Infect Dis
; 15(4): 571-3, 2009 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-19331734